Catalog No.:AA01S7JQ

1190389-15-1 | Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-

Name: Name:Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-
Brand: AABLOCKS
SKU: AA01S7JQ
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

98%

1 week

$416.00 $291.00

- +

5mg

98%

1 week

$987.00 $691.00

- +

10mg

98%

1 week

$1,558.00 $1,091.00

- +

25mg

98%

1 week

$3,066.00 $2,147.00

- +

50mg

98%

1 week

$4,892.00 $3,424.00

- +

100mg

98%

1 week

$7,828.00 $5,480.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information

Catalog Number:

AA01S7JQ

Chemical Name:

Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-

CAS Number:

1190389-15-1

Molecular Formula:

C26H28N4O3

Molecular Weight:

444.5255

MDL Number:

MFCD28502057

SMILES:

O=C([C@@H]1CCc2n1c(=O)ccn2)Nc1ccc(cc1)C[C@@H]1CC[C@@H](N1)[C@@H](c1ccccc1)O

Properties

Literature

Title: Yoshida M, et al. Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study. BJU Int. 2020;125(5):709-717.

Title: Yoshida M, et al. Efficacy of novel β3 -adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. Int J Urol. 2019;26(3):369-375.

Title: Edmondson SD, et al. Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. J Med Chem. 2016;59(2):609-623.

Title: Gotoh D, et al. Effects of a new β3-adrenoceptor agonist, vibegron, on neurogenic bladder dysfunction and remodeling in mice with spinal cord injury. Neurourol Urodyn. 2020;39(8):2120-2127.

Title: Furuta A, et al. Additive effects of intravenous and intravesical application of vibegron, a β3-adrenoceptor agonist, on bladder function in rats with bladder overactivity. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(11):2073-2080.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

Submit

SDS

Related Products of 1190389-15-1

Building Blocks

More >

Historical Records

901728-56-1

Tags:1190389-15-1 Molecular Formula|1190389-15-1 MDL|1190389-15-1 SMILES|1190389-15-1 Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-

Catalog No.: AA01S7JQ

1190389-15-1 | Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-

Pack Size： 1mg

Purity： 98%

1 week

$416.00 $291.00

Pack Size： 5mg

Purity： 98%

1 week

$987.00 $691.00

Pack Size： 10mg

Purity： 98%

1 week

$1,558.00 $1,091.00

Pack Size： 25mg

Purity： 98%

1 week

$3,066.00 $2,147.00

Pack Size： 50mg

Purity： 98%

1 week

$4,892.00 $3,424.00

Pack Size： 100mg

Purity： 98%

1 week

$7,828.00 $5,480.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA01S7JQ

Chemical Name: Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)-

CAS Number: 1190389-15-1

Molecular Formula: C26H28N4O3

Molecular Weight: 444.5255

MDL Number: MFCD28502057

SMILES: O=C([C@@H]1CCc2n1c(=O)ccn2)Nc1ccc(cc1)C[C@@H]1CC[C@@H](N1)[C@@H](c1ccccc1)O

Properties

Building Blocks More >

Submit